Simplified approach to investigation of suspected VTE
|
|
- Dominick Sullivan
- 6 years ago
- Views:
Transcription
1 Simplified approach to investigation of suspected VTE Diagnosis of DVT and PE THSNA 2016, Chicago 15 April 2016 Clive Kearon, McMaster University, Canada
2 Relevant Disclosures Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board Canadian Institutes Health Research Heart & Stroke Foundation of Ontario National Institutes of Health Bayer Inc. No relevant Bayer Inc. No relevant No relevant No relevant No relevant
3 Outline Goals of diagnostic testing Ruling-in & Rule-out VTE Clinical evaluation as a diagnostic test D-dimer (with clinical evaluation) Imaging tests for DVT and PE Diagnostic combinations Difficult diagnostic situations
4 Goal of Diagnostic Testing for DVT & PE Who needs treatment have VTE & Anticoagulants will do more good than harm Who doesn t need treatment don t have VTE OR VTE but anticoags more harm than good (will resolve and won t recur without Rx) Need to narrow differential diagnosis
5 Ruling-in and Ruling-out a Diagnosis What level of certainty is acceptable?
6 Ruling-in and Ruling-out a Diagnosis What level of certainty is acceptable? Ruling-in (to treat) Depends on toxicity of treatment - high certainty if toxic Ruling-out (not to treat) Depends on consequences of missed diagnosis - high certainty if:(i) rapidly fatal and (ii) effective treatment
7 Ruling-in DVT or PE Probability of PE ³85% Anticoagulants are toxic (~4% bleeding 3 m) Ruling-out DVT or PE Probability recurrent VTE 2% Recurrent PE may be fatal Anticoagulants are very effective (~ 80% RR)
8 100% 85% VTE Diagnosed 50% 2% 0% VTE Excluded management
9 100% 85% PTP prevalence VTE Diagnosed 50% ~25% 2% 0% VTE Excluded management
10 First diagnostic assessment
11 Clinical Assessment of DVT & PE Signs and symptoms Risk factor for VTE Alternative diagnosis as likely
12 Alternative diagnosis as likely -2 Active cancer 1 Paralysis, paresis or plaster cast 1 Bedridden > 3 days (1 month) 1 Tenderness of deep veins 1 Entire leg swollen 1 Calf swelling (3 cm > other leg) 1 Pitting edema 1 Dilated superficial veins 1 History of VTE 1 Total points Clinical Assessment: Low: < 1; Moderate: 1-2; High > 2 for first or recurrent DVT Wells, J Intern Med 1998 Geersing BMJ 2014
13 No other more likely diagnosis 3 Signs & Symptoms of DVT (tender/swelling) 3 Active cancer 1 Previous DVT or PE 1.5 Immobilization / Surgery <4 weeks 1.5 Heart rate > 100/min 1.5 Hemoptysis 1 Total points Clinical Assessment: Low or Unlikely: < 4.5 for PE Wells, Thromb Haemost 2000 Moderate: 4.5-6; High: > 6
14 Wells Model for DVT & PE Clinical Suspicion Prevalence VTE High Moderate Low (15% of patients) (35% of patients) (50% of patients) 75% 25% <10%
15 Wells Model for DVT & PE Clinical Suspicion High Moderate Low Prevalence VTE 75% 25% <10% Likelihood Ratio ~8 ~1 ~0.3
16 100% 85% PTP Clinical PTP VTE Diagnosed High 50% Moderate Low 2% 0% VTE Excluded management
17 D-dimer
18 Cross-linked fibrin Plasmin D-dimer
19 Almost always increased with acute VTE (sensitive test) Increased by other conditions and age (non-specific test)
20 D-dimer Very sensitive: very high NPV, rarely negative ( 95%) ( 98%) (~30%) e.g. D-dimer <500 ug FEU/L Mod sensitive: lower NPV, often negative (~90%) (~95%) (~60%) e.g. SimpliRED +ive or ive
21 100% 85% 50% ~25% PTP prevalence Very Sensitive D-dimer Positive VTE Diagnosed High C-PTP rarely negative lower NPV not worth doing 2% 0% Negative VTE Excluded management
22 100% 85% PTP prevalence Moderately Sensitive D-dimer Mod Sen D-dimer + PTP 50% ~25% 2% 0% Negative Negative + Low PTP
23 To get more negative D-dimers
24 To get more negative D-dimers Increase D-dimer threshold (higher specificity & lower sensitivity) Two ways proposed
25 Age-adjusted D-dimer threshold Theory: Because D-dimer increases with age, can use higher threshold in elderly 50 years Threshold 500ug/L >50 years Threshold = age x 10 ug/l e.g. 78 years x 10 = 780ug/L
26 Age-adjusted D-dimer threshold Supported by: Many retrospective analyses for DVT and PE One prospective cohort of suspected PE Non-high C-PTP & D-dimer 500 to Age x 10 Prevalence: 337/3346 (10.1%) VTE at 3 mo: 1/331 (0.3%, 95%CI ) Righini for ADJUST-PE JAMA 2014
27 C-PTP-adjusted D-dimer threshold Theory: Because less VTE with low C-PTP, can exclude VTE with much higher D-dimer Low C-PTP Threshold 1,000ug/L Moderate C-PTP Threshold 500ug/L 2-fold difference
28 C-PTP-adjusted D-dimer threshold Supported by: Some retrospective analyses for DVT and PE One randomized trial in suspected DVT Low C-PTP CPTP & D-dimer 500 to 999 Prevalence in outpatients: 169/1422 (11.9%) VTE at 3 mo: 0/169 (0%, 95%CI ) RCT comparison: -0.3% (95%CI -1.8 to 0.8) Linkins for SELECT Ann Intern Med 2013
29 D-dimer not worth doing if: Very unlikely to get a negative result very high C-PTP another reason for a positive test Low NPV will not change management very high C-PTP Eg: After surgery; cancer; sepsis
30 Okay! When you can t rule out DVT or PE with Clinical PTP & D-dimer?
31 Diagnostic Imaging for DVT
32 Compression Ultrasonography (CUS) Imaging Test of Choice for DVT
33 US probe US probe No compression Compression
34 Common Femoral Proximal US Whole leg US Calf v. Trifurcation
35 Proximal US Common Femoral Calf v. Trifurcation easy accurate DVT important often diagnostic with C-PTP or D-d alone, does not exclude all DVT may require 2 nd US after 1 week
36 Whole leg US Common Femoral Calf v. Trifurcation (with distal veins) more complex less accurate DVT of uncertain importance excludes all DVT Distal US may be an unhelpful additional test
37 Diagnostic for First DVT US of proximal veins Venography (ascending, CT, MRI) Excludes DVT (including recurrent) Two of: Low C-PTP Negative D-dimer (moderate sensitivity) Negative proximal CUS (or no new vs. pervious) Negative proximal CUS on Day 1 and 7 (serial US) Negative ultrasound of all deep veins Negative D-dimer (very sensitive + non-high C-PTP) Venography of all deep veins
38 Recurrent DVT: additional criteria (thrombus can persist indefinitely) Diagnostic for Recurrent DVT New DVT on proximal US compared to previous (new CFV, Pop, Tri; 4 mm diam; 10 cm longer) Venography (ascending, CT, direct thrombus imaging MRI) Excludes recurrent DVT No new DVT on serial testing (Day 7, Day 14) No acute findings on venography (ascend, CT, MRI)
39 Diagnostic Imaging for PE
40 CT Pulmonary Angiography (CTPA)
41 No PE on CTPA ( & good quality study [~95%]) Multidetector CT, 12 studies; 2982 patients VTE 3 mo follow-up: 1.1% (95% CI ) Carrier J Thromb Haemost 2010
42 Positive Predictive Value of CT by Anatomical Level & Clinical Assessment Clinical Suspicion High Intermed. Low All Main / lobar 96% 99% 89% 97% Segmental 100% 79% 64% 68% Sub-seg. none ~33% ~20% 25%
43 Positive Predictive Value of CT by Anatomical Level & Clinical Assessment Clinical Suspicion High Intermed. Low All Main / lobar 96% 99% 89% 97% Segmental 100% 79% 64% 68% Sub-seg. none ~33% ~20% 25%
44 Ventilation-Perfusion Scanning
45 Ventilation-Perfusion Scanning Often preferred to CTPA Renal impairment Contrast dye allergy Younger (esp. females <40 yr) Pregnancy
46 Ventilation/Perfusion Scan and Clinical Assessment Normal perfusion ~25% Hi-prob & mod/high PTP ~10% Other combinations ~65% (overall prevalence of PE ~20%) PE - + +
47 SPECT V/Q scanning (single-photon emission CT) 3 D ventilation and perfusion imaging better resolution of defects than 2D planar non-diagnostic reduced from ~60% to 5% the general impression is that SPECT is better than planar Stein J Nucl Med 2009; SNM practice Guidelines J Nucl Med 2012
48 SPECT V/Q scanning BUT, NO: Large, prospective, multicentre studies WITH Blind comparison with a criterion standard OR Follow-up after withholding anticoagulation with No PE interpretation
49 Non-diagnostic combinations DVT Hx VTE, abnormal US, D-dimer +ive (Serial US; may treat) Small abnormality on US, D-dimer +ive (Serial US; may treat) PE Non-diagnostic CTPA (technical, small ILFD, Hx VTE) & no DVT & D-dimer +ive (Serial US; 2 nd CTPA) SPECT non-diagnostic V/Q (no CTPA; renal failure) & no DVT & D-dimer +ive (Serial US;?CTPA)
50 Conclusions There is no right way to diagnose DVT & PE (many effective strategies) C-PTP and D-dimer can often exclude DVT/PE Can t always reach a definitive diagnosis Can manage safely when can t reach a definitive diagnosis (often serial tests for DVT)
Diagnostic Algorithms in VTE
Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)
More informationClinical Guide - Suspected PE (Reviewed 2006)
Clinical Guide - Suspected (Reviewed 2006) Principal Developer: B. Geerts Secondary Developers: C. Demers, C. Kearon Background Investigation of patients with suspected pulmonary emboli () remains problematic
More informationDiagnosis of Venous Thromboembolism
Diagnosis of Venous Thromboembolism An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric Tseng MD MScCH, University of
More informationDVT Diagnosis. Reference methods. Whole leg Ultrasonography. Predictive values. Page 1. Diagnosis of 1 st time symptomatic DVT.
DVT Diagnosis Ulf Nyman Associate Professor Lund University Department of Radiology East Division (Kristianstad, HässleholmH Trelleborg, Ystad) Sweden Diagnosis of 1 st time symptomatic DVT Scientific
More informationNew Guidance in AT10 Clive Kearon, MD, PhD,
New Guidance in AT10 Clive Kearon, MD, PhD, Professor, Department of Medicine, McMaster University; Program Director, McMaster Clinical Investigator Program, McMaster University Head, Clinical Thromboembolism
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationFrom the Departments of Medicine, University of Ottawa, Ottawa, Canada, McMaster University, Hamilton, Canada, Dalhousie University, Halifax, Canada
2000 Schattauer Verlag, Stuttgart Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer Philip S. Wells,
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationApproach to Thrombosis
Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation
More informationEpidermiology Early pulmonary embolism
Epidermiology Early pulmonary embolism Sitang Nirattisaikul Faculty of Medicine, Prince of Songkla University 3 rd most common cause of cardiovascular death in the United States, following ischemic heart
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationCHAPTER 2 VENOUS THROMBOEMBOLISM
CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology
More informationAntithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
CHEST Supplement ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES Diagnosis of Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians
More informationThe latest on the diagnosis and treatment of venous thromboembolism
The latest on the diagnosis and treatment of venous thromboembolism Vicky Tagalakis MD FRCP Division of General Internal Medicine Jewish General Hospital McGill University Disclosures Advisory board Pfizer
More informationDiagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go?
Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go? Philip S. Wells MD, FRCPC, MSc Professor Chair and Chief, Department of Medicine, University of Ottawa DISCLOSURE
More informationPULMONARY EMBOLISM/VTE CARE PROCESS MODEL
PULMONARY EMBOLISM/VTE CARE PROCESS MODEL IMCP FALL CONFERENCE 2017 Scott Stevens, MD Co-Director, Thrombosis Clinic & Thrombosis Research Group Intermountain Medical Center Professor of Clinical Medicine
More informationIl D-dimero: vantaggi e limiti
XXVI Congresso Nazionale FCSA Bologna 5-7 Novembre 2015 Il D-dimero: vantaggi e limiti Gualtiero Palareti Cardiovascular diseases University of Bologna, Italy Degradation of stabilized fibrin DD= Methodolgical
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue
More informationED Diagnosis of DVT or tools to rule out DVT in your ED
ED Diagnosis of DVT or tools to rule out DVT in your ED Ralph Wang UCSF Department of Emergency Medicine 53 yo f c/o left leg swelling recent cholecystectomy its midnight how do you manage this patient?
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationDiagnosis and management of pulmonary embolism
Follow the link from the online version of this article to obtain certified continuing medical education credits bmj.com Respiratory Medicine updates from BMJ Group are at bmj.com/specialties/respiratory-medicine
More informationKeynote lecture: Oral anticoagulation and DVT
Keynote lecture: Oral anticoagulation and DVT What is the evidence? Is there a need to anticoagulate every lower leg DVT? Disclosure Speaker name:...sebastian Schellong... I have the following potential
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationPULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)
More informationPulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical
Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases
More informationACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE
. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 003; 5():-5.. Hamper UM, DeJong MR, Scoutt LM. Ultrasound
More informationUnderstanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal
Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria
More informationProvider Led Entity. CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018
Provider Led Entity CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018 Appropriateness of advanced imaging procedures* in patients with suspected or known pulmonary embolus and the following
More informationIndividualized prediction in pulmonary embolism; novel concepts and future ideas. Geert-Jan Geersing, MD PhD Family Medicine specialist
Individualized prediction in pulmonary embolism; novel concepts and future ideas. Geert-Jan Geersing, MD PhD Family Medicine specialist Our thrombosis research Since then: 50+ papers Guidelines primary
More informationDr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust
MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital
More informationPulmonary Thromboembolism
Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU
More informationD-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis
Original Contribution This is Advance Publication Article Kurume Medical Journal, 60, 00-00, 2013 D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis SHINICHI NATA, SHINICHI
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More information8,9,10. Deep venous thrombosis (DVT) is clotting of blood in a deep vein of Pulmonary embolism
CANCER ASSOCIATED THROMBOSIS DIAGNOSIS OF VTE In patients with cancer-associated thrombosis, landmark studies have demonstrated that effective prophylaxis and treatment of thrombosis reduces morbidity
More informationMutidisciplinary cooperation on VTE prevention and managment
Mutidisciplinary cooperation on VTE prevention and managment TAO YANG Dpartment of vascular surgery Shanxi DAYI Hospita Tai yuan Shanxi China Disclosure Speaker name: Tao Yang... I have the following potential
More informationThromboembolism and cancer: New practices. Marc Carrier
Thromboembolism and cancer: New practices Marc Carrier Marc Carrier Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board Leo Pharma, BMS No relevant
More informationAnticoagulation Forum: Management of Tiny Clots
Anticoagulation Forum: Management of Tiny Clots Casey O Connell, MD FACP Associate Professor Jane Anne Nohl Division of Hematology Keck School of Medicine USC DISCLOSURES None 4/11/2017 Objectives Define
More informationVenous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Appendix A: Summary of new evidence from Summary of evidence from previous year Diagnosis Diagnostic
More informationPulmonary embolism: assessment and imaging
clinical Sarah Skinner Pulmonary embolism: assessment and imaging Keywords pulmonary embolism; radionuclide imaging; pulmonary embolism/radiography It is estimated that there are approximately 17 000 new
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationJeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?
Pulmonary Embolism Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital Disclosure No Financial Relationships to Disclose No significant investments
More informationScanning the Literature
Scanning the Literature Joseph Breault, MD, MPHTM Joseph Guarisco, MD Spiral CTs Are Cost-Effective Paterson DI, Schwartzman K. Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism:
More informationRadiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA
Radiation Exposure in Pregnancy John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Illustrative Clinical Scenario 32 year old female 34 weeks pregnant with recent onset shortness of breath and central chest pain
More informationUltrasonography and Diagnosis of Venous Thromboembolism
Ultrasonography and Diagnosis of Venous Thromboembolism Brenda K. Zierler, PhD Abstract Venous thromboembolism (VTE) consists of two related conditions: pulmonary embolism (PE) and deep vein thrombosis
More informationBACKGROUND METHODS RESULTS CONCLUSIONS
CHAPTER 5 The combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis R.E.G. Schutgens 1, P. Ackermark 2, F.J.L.M.
More informationUpdates in Diagnosis & Management of VTE
Updates in Diagnosis & Management of VTE Financial Disclosures-NONE TRACY MINICHIELLO, MD CHIEF, ANTICOAGULATION& THROMBOSIS SERVICE- SAN FRANCISCO VAMC PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA,
More informationAge-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism
James Madison University JMU Scholarly Commons Physician Assistant Capstones The Graduate School 5-16-2017 Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism Kirsten
More informationVenous Thromboembolic Disease Update
Canadian Society of Internal Medicine Annual Meeting Calgary, Alberta, October 2014 Venous Thromboembolic Disease Update Benjamin Bell, MD FRCPC James Douketis, MD FRCPC On Behalf of Thrombosis Canada
More informationImplications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach
Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely
More informationToo much medicine and venous thromboembolism: How can we make things Well again?
Too much medicine and venous thromboembolism: How can we make things Well again? Emily G McDonald MD MSc; Assistant professor of medicine; McGill University Health Centre Canadian Society of Internal Medicine;
More informationPatients with suspected DVT of the lower limb how to exam the patient
Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology
More informationDVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre
DVT and Pulmonary Embolus Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre Overview Structure of deep and superficial venous system of upper
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationWhat s New in DVT & PE
What s New in DVT & PE Mark Buch MD CM CCFP(EM) Attending physician Emergency Department Jewish General Hospital Family Physician and Medical Director GMF Santé Mont-Royal Objectives: Review the diagnostic
More informationTrombosi venose superficiali e trombosi venose distali
XXIV Congresso Nazionale SISET Abano 9-12 Novembre 2016 Trombosi venose superficiali e trombosi venose distali Gualtiero Palareti / Benilde Cosmi Università di Bologna Superficial vein thrombosis (SVT):
More informationDiscussion Leader: Doug Bias, M.D.
In low-risk patients with isolated calf DVT (IDDVT), what is the morbidity risk of treating with repeat ultrasound/observation versus anticoagulation? Discussion Leader: Doug Bias, M.D. Clinical Scenario:
More informationIs it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital
Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital A few definitions Safe Avoid death, recurrent thrombosis, bleeding Manage Diagnosis + treatment Pulmonary embolism
More informationHow to Diagnose Pulmonary Embolism anno 2014?
How to Diagnose Pulmonary Embolism anno 2014? Mark H.H. Kramer, MD, PhD, FRCP FACP Professor of Medicine VU University Medical Center Amsterdam, The Netherlands What are we going to discuss? Age adjusted
More informationOral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study.
Oral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study Comments Harald Darius, Berlin Disclosures for Harald Darius Research
More informationExpanding the treatment options of Superficial vein thrombosis with Rivaroxaban
Expanding the treatment options of Superficial vein thrombosis with Rivaroxaban Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationClinical Reasoning: Use of Diagnostic Testing
Clinical Reasoning: Use of Diagnostic Testing Viju John, MD OCTOBER 21, 2016 Objectives 1. Determine pre and post-test probability. 2. Understand the concepts of threshold to test and a threshold to treat.
More informationDuration of Therapy for Venous Thromboembolism
Duration of Therapy for Venous Thromboembolism Michael B Streiff, MD FACP Associate Professor of Medicine and Pathology Medical Director, Johns Hopkins Anticoagulation Service Chairman, VTE Guideline Committee
More informationDuration of anticoagulation
Duration of anticoagulation P. Fontana Service d angiologie et d hémostase Hôpitaux Universitaires de Genève Pomeriggio formativo in coagulazione, Bellinzona, 19.10.2017 Conflict of interest AstraZeneca,
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationORIGINAL INVESTIGATION
Use of a Clinical Decision Rule in Combination With D-Dimer Concentration in Diagnostic Workup of Patients With Suspected Pulmonary Embolism A Prospective Management Study ORIGINAL INVESTIGATION Marieke
More informationUnderuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism
Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism Michael Perera Advanced Trainee in General and Acute Medicine Leena Aggarwal Director, Medical Assessment
More informationWhat is the impact of Superficial Vein Thrombosis?
What is the impact of Superficial Vein Thrombosis? Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, University of Thessalia, Greece Chairman,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationPulmonary embolism? A rapid disposition can be a matter of life or death.
Pulmonary embolism? A rapid disposition can be a matter of life or death. Not all D-dimer tests are created equal. D-dimer assays are known to have varying sensitivities. 8,9,10 ELISA and FIA assays have
More informationSupplementary Online Content
Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone
More informationCanadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC
Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM
More informationPulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy
Pulmonary embolism: Acute management Cecilia Becattini University of Perugia, Italy Acute pulmonary embolism: Acute management Diagnosis Risk stratification Treatment Non-high risk PE: diagnosis 3-mo VTE
More informationDifferences in clinical presentation of pulmonary embolism in women and men
Journal of Thrombosis and Haemostasis, 8: 693 698 DOI: 10.1111/j.1538-7836.2010.03774.x ORIGINAL ARTICLE Differences in clinical presentation of pulmonary embolism in women and men H. ROBERT-EBADI,* G.
More informationControversies in Venous Thromboembolism
Controversies in Venous Thromboembolism Menaka Pai, BSc MSc MD FRCPC Assistant Professor, Department of Medicine, McMaster University Associate Member, Department of Pathology and Molecular Medicine, McMaster
More informationDVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
More informationSuspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range
Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page
More informationAuthor(s): Rockefeller A. Oteng, M.D., University of Michigan
Project: Ghana Emergency Medicine Collaborative Document Title: Pulmonary Embolism Part 2 (2012) Author(s): Rockefeller A. Oteng, M.D., University of Michigan License: Unless otherwise noted, this material
More informationsuspected deep-vein thrombosis is a common condition, with a lifetime cumulative incidence of 2 to 5 percent. Untreated deep-vein thrombosis can resul
original article Evaluation of d-dimer in the Diagnosis of Suspected Deep-Vein Thrombosis Philip S. Wells, M.D., David R. Anderson, M.D., Marc Rodger, M.D., Melissa Forgie, M.D., Clive Kearon, M.D., Ph.D.,
More informationAssessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department
Assessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department Herman Tagger 1, Helene Kildegaard Jensen 2, Annmarie Touborg Lassen 2, Ulf Ekelund
More informationDuration of Anticoagulant Therapy. Linda R. Kelly PharmD, PhC, CACP September 17, 2016
Duration of Anticoagulant Therapy Linda R. Kelly PharmD, PhC, CACP September 17, 2016 Conflicts of Interest No conflicts of interest to report Objectives At the end of the program participants will be
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL
More informationNew areas of development for the direct oral anticoagulants
New areas of development for the direct oral anticoagulants Varese March 2016 Disclosures for Harry R Büller Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Scientific Advisory
More informationCitation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis
UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:
More informationAcute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT
Acute Pulmonary Embolism and Deep Vein Thrombosis Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center Acute PE and DVT No disclosures. Acute PE and DVT Learning objectives
More informationDr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationRisk-Based Evaluation and Management of VTE
12:50-1:50pm Risk-Based Evaluation and Management of VTE SPEAKER Gregory Piazza, MD, MS BRIGHAM AND WOMEN S HOSPITAL Risk-Based Evaluation and Management of VTE Gregory Piazza, MD, MS Assistant Professor
More informationCanadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON
Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON How to Prevent and Manage the Post-Thrombotic Syndrome? Jean-Philippe Galanaud Clinical Thromboembolism & Division of GIM Sunnybrook,
More informationClinical Cases with Deep Venous Thrombosis - The position of Apixaban Stavros KAKKOS, MD, MSc, PhD, RVT
Clinical Cases with Deep Venous Thrombosis - The position of Apixaban Stavros KAKKOS, MD, MSc, PhD, RVT Department of Vascular Surgery. University Hospital of Patras Chairman: Ioannis Tsolakis DISCLAIMER
More informationIndications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute
Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute Disclosures Research Support/P.I. Employee Leo Pharma
More informationBlood Day for Primary Care
Blood Day for Primary Care including the Anticoagulation, use of novel oral anticoagulants in DVT/PE & atrial fibrillation Marc Carrier MD MSc. FRCPC Department of Internal Medicine, Division of Hematology,
More informationCitation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis
UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue
More informationAnticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis
Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Tim Sebastian, M.D. University Hospital Zurich Clinic for Angiology Disclosure Speaker name: Tim Sebastian I
More informationPulmonary Embolism. Thoracic radiologist Helena Lauri
Pulmonary Embolism Thoracic radiologist Helena Lauri 8.5.2017 Statistics 1-2 out of 1000 adults annually are diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) About half of patients
More information